Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease
JAMA Neurology Author Interviews - Un pódcast de JAMA Network - Lunes
Interview with Charbel Moussa, MD, PhD, author of Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial
